Beauty Health's (NASDAQ:SKIN) fiscal 2021 first quarter gave its bulls a reason to cheer with a beat on revenue estimates and an increase in adjusted gross margins to 75% from 51% in the year-ago quarter. The company
Beauty Health: Q2 Results Support The Bull Thesis
Summary
- Beauty Health's fiscal 2021 second quarter results were a strong beat on analyst estimates.
- Operational momentum during the quarter led the company to raise its revenue guidance for the year.
- With a high cash balance and positive adjusted net income, Beauty Health has built a strong foundation as it plots greater international expansion.
The equity market is a powerful mechanism as daily fluctuations in price get aggregated to incredible wealth creation or destruction over the long term. Pacifica Yield aims to pursue long-term wealth creation with a focus on undervalued yet high-growth companies, high-dividend tickers, REITs, and green energy firms.
Analyst’s Disclosure:I/we have a beneficial long position in the shares of SKIN either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.